Literature DB >> 12641566

Increased levels of the translation initiation factor eIF4E in differentiating epithelial lung tumor cell lines.

Derek Walsh1, Paula Meleady, Brendan Power, Simon J Morley, Martin Clynes.   

Abstract

Rates of eukaryotic protein synthesis and proliferation are dependent upon the availability of eIF4F, the cap-binding translation initiation complex that guides the ribosome onto the mRNA. One possible rate-limiting factor in eIF4F complex formation is the availability of eIF4E, which interacts specifically with the mRNA cap structure. As such, it has a potential role in the selective translation of growth-related mRNAs, with overexpression of eIF4E resulting in aberrant cell growth and transformation. A number of studies suggest that eIF4E may play a role in cellular differentiation as well as proliferation. We have previously reported that post-transcriptional regulation is involved in the induction of keratins in epithelial lung tumor cell lines exposed to the differentiation-modulating agent, bromo-deoxyuridine (BrdU). Here, we demonstrate that these BrdU-treated lung cells express elevated levels of eIF4E protein and enhanced phosphorylation of eIF4E. Overexpression of eIF4E by cDNA transfection in the poorly differentiated, keratin-negative human lung cell line, DLKP, was found to promote a flattened, more epithelial appearance to these cells, coupled with the induction of simple keratins (keratins 8 and 18). In contrast, levels of eIF4E expression were found to decrease during BrdU-induced differentiation of the leukemic cell line, HL-60, suggesting that there are cell-type differences in the response to BrdU and in the requirement for eIF4E during differentiation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12641566     DOI: 10.1046/j.1432-0436.2003.710203.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  7 in total

Review 1.  Weighing up the possibilities: Controlling translation by ubiquitylation and sumoylation.

Authors:  Felicity Z Watts; Robert Baldock; Jirapas Jongjitwimol; Simon J Morley
Journal:  Translation (Austin)       Date:  2014-10-30

2.  Deregulation of eIF4E: 4E-BP1 in differentiated human papillomavirus-containing cells leads to high levels of expression of the E7 oncoprotein.

Authors:  Kwang-Jin Oh; Anna Kalinina; No-Hee Park; Srilata Bagchi
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinoma.

Authors:  Mengyan Wu; Yingxia Liu; Xiaoqing Di; Haixian Kang; Hua Zeng; Yi Zhao; Kangrong Cai; Tianyun Pang; Sen Wang; Yunhong Yao; Xinrong Hu
Journal:  Med Oncol       Date:  2013-01-01       Impact factor: 3.064

4.  hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation.

Authors:  Mary Lynch; Li Chen; Michael J Ravitz; Sapna Mehtani; Kevin Korenblat; Michael J Pazin; Emmett V Schmidt
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

5.  Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells.

Authors:  Derek Walsh; Ian Mohr
Journal:  Genes Dev       Date:  2004-03-15       Impact factor: 11.361

6.  Treatment of breast and lung cancer cells with a N-7 benzyl guanosine monophosphate tryptamine phosphoramidate pronucleotide (4Ei-1) results in chemosensitization to gemcitabine and induced eIF4E proteasomal degradation.

Authors:  Shui Li; Yan Jia; Blake Jacobson; Joel McCauley; Robert Kratzke; Peter B Bitterman; Carston R Wagner
Journal:  Mol Pharm       Date:  2013-02-04       Impact factor: 4.939

7.  Assembly of an active translation initiation factor complex by a viral protein.

Authors:  Derek Walsh; Ian Mohr
Journal:  Genes Dev       Date:  2006-02-15       Impact factor: 11.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.